120 related articles for article (PubMed ID: 38688171)
1. In vitro study of cold atmospheric plasma-activated liquids inhibits malignant melanoma by affecting macrophage polarization through the ROS/JAK2/STAT1 pathway.
Chen C; Zhou S; Yang X; Ren M; Qi Y; Mao Y; Yang C
Biomed Pharmacother; 2024 Jun; 175():116657. PubMed ID: 38688171
[TBL] [Abstract][Full Text] [Related]
2. Tramadol suppresses growth of orthotopic liver tumors via promoting M1 macrophage polarization in the tumor microenvironment.
Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4205-4218. PubMed ID: 38041778
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
4. Non-invasive Physical Plasma Modulates Macrophage Polarization: A Potential Strategy for Tumor Microenvironment Remodeling.
Niu Y; Förster S; Badendieck S; Nokhbehsaim M; Abazid A; Stope MB
Anticancer Res; 2024 Jun; 44(6):2437-2444. PubMed ID: 38821624
[TBL] [Abstract][Full Text] [Related]
5. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
[TBL] [Abstract][Full Text] [Related]
6. Ferumoxytol-β-glucan Inhibits Melanoma Growth via Interacting with Dectin-1 to Polarize Macrophages into M1 Phenotype.
Liu X; Xu Y; Li Y; Pan Y; Zhao S; Hou Y
Int J Med Sci; 2021; 18(14):3125-3139. PubMed ID: 34400883
[No Abstract] [Full Text] [Related]
7. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
8. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/SOCS1 and STAT1/CIITA pathways to promote the progression of non-small cell lung cancer.
Yin C; Li J; Li S; Yang X; Lu Y; Wang C; Liu B
Cell Signal; 2024 Mar; 115():111031. PubMed ID: 38168631
[TBL] [Abstract][Full Text] [Related]
10. Dioscin induces M1 macrophage polarization through Connexin-43 Channels in Tumor-associated-macrophages-mediated melanoma metastasis.
Kou Y; Sun Q; Zhu R; Lin Z; Li Z; Xu H; Feng X; Liu Y
Phytomedicine; 2023 Jan; 109():154559. PubMed ID: 36610151
[TBL] [Abstract][Full Text] [Related]
11. A cross-linked macropore hydrogel based on M1 macrophage lysate and alginate regulates tumor-associated macrophages for the treatment of melanoma.
Li W; Ye Q; Jiang Z; Xia D; Yan Z; Wang D; Chen Y; Cao T; Wang J; Lin C; Yang H; Deng J; Lin J
Int J Biol Macromol; 2024 Jun; 269(Pt 2):132089. PubMed ID: 38705331
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer.
Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y
J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267
[TBL] [Abstract][Full Text] [Related]
13. Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment.
Jia W; Luo S; Lai G; Li S; Huo S; Li M; Zeng X
BMC Complement Med Ther; 2021 May; 21(1):150. PubMed ID: 34034714
[TBL] [Abstract][Full Text] [Related]
14. A Stat1 bound enhancer promotes Nampt expression and function within tumor associated macrophages.
Huffaker TB; Ekiz HA; Barba C; Lee SH; Runtsch MC; Nelson MC; Bauer KM; Tang WW; Mosbruger TL; Cox JE; Round JL; Voth WP; O'Connell RM
Nat Commun; 2021 May; 12(1):2620. PubMed ID: 33976173
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of EMR1 (ADGRE1) by Tumor-Associated Macrophages Promotes Colon Cancer Progression by Activating the JAK2/STAT1,3 Signaling Pathway in Tumor Cells.
Akter R; Park R; Lee SK; Han EJ; Park KS; Park J; Cho MY
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673975
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A inhibits M1 macrophage polarization by deactivation of JAK2/STAT1 and IκB/NFκB pathway and contributes to scar alleviation in aseptic skin wound healing.
Zou YP; Shan XF; Qiu JX; Wang LN; Xiang RL; Cai ZG
Biomed Pharmacother; 2024 May; 174():116468. PubMed ID: 38518603
[TBL] [Abstract][Full Text] [Related]
17. HuoXueTongFu Formula Alleviates Intraperitoneal Adhesion by Regulating Macrophage Polarization and the SOCS/JAK2/STAT/PPAR-
Zhao M; Bian YY; Yang LL; Chen YQ; Wang YJ; Ma YT; Pei YQ; Li WL; Zeng L
Mediators Inflamm; 2019; 2019():1769374. PubMed ID: 31772499
[TBL] [Abstract][Full Text] [Related]
18. Extracts of Cordyceps sinensis inhibit breast cancer growth through promoting M1 macrophage polarization via NF-κB pathway activation.
Li J; Cai H; Sun H; Qu J; Zhao B; Hu X; Li W; Qian Z; Yu X; Kang F; Wang W; Zou Z; Gu B; Xu K
J Ethnopharmacol; 2020 Oct; 260():112969. PubMed ID: 32422358
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
Li X; Li Z; Li X; Liu B; Liu Z
BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
[TBL] [Abstract][Full Text] [Related]
20. Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression.
Rauca VF; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Mot AC; Rakosy-Tican E; Sesarman A; Banciu M
Sci Rep; 2021 Nov; 11(1):22102. PubMed ID: 34764332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
